CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma
Clinical trial NCT04083495 · RECRUITING
Trial details
- NCT number
- NCT04083495
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-17
- Primary completion
- 2028-02-23
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.